Exact Mass: 383.2373
Exact Mass Matches: 383.2373
Found 83 metabolites which its exact mass value is equals to given mass value 383.2373,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(E,E,E)-Sylvatine
(Z,2E,4Z)-5-(2H-1,3-benzodioxol-5-yl)-N-[(5E)-10-methylundec-5-en-1-yl]penta-2,4-dienimidic acid
(E,E,E)-Sylvatine is an alkaloid from Piper chaba (Javanese long pepper) and several other Piper species (Piperaceae Alkaloid from Piper chaba (Javanese long pepper) and several other Piper subspecies (Piperaceae).
(1R,7S)-4-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]deca-2,5-diene-3,5-diol
(1R,7S)-4-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]deca-2,5-diene-3,5-diol
N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
Denaverine
2-(dimethylamino)ethyl 2-(2-ethylbutoxy)-2,2-diphenylacetate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
Naftidrofuryl
2-(diethylamino)ethyl 3-(naphthalen-1-yl)-2-(oxolan-2-ylmethyl)propanoate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Tandospirone
2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
Guineensine
(2E,4E,12E)-13-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)trideca-2,4,12-trienamide
Guineensine, also known as pipyahyine, is a member of the class of compounds known as benzodioxoles. Benzodioxoles are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms. Guineensine is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Guineensine can be found in pepper (spice), which makes guineensine a potential biomarker for the consumption of this food product. Guineesine (or guineensine) is an alkaloid isolated from long pepper (Piper longum) and black pepper (Piper nigrum) .
nafronyl
Naftidrofuryl
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
3alpha-N-acetyl-N-methylaminopregn-4,6-diene-18,20-lactone|kibalaurifoline
3alpha-N-acetyl-N-methylaminopregn-4,6-diene-18,20-lactone|kibalaurifoline
13-(3-(2-methoxyphenyl)-1-azapropyl) isoalantolactone
NCGC00160348-01!13-(3-(2-methoxyphenyl)-1-azapropyl) isoalantolactone
(2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)trideca-2,4,12-trienamide
NCGC00247500-02!(2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)trideca-2,4,12-trienamide
C19H33N3O5_2,8-Diisobutyl-5-methyl-1-oxa-4,7,10-triazacyclotetradecane-3,6,9,14-tetrone
NCGC00386076-01_C19H33N3O5_2,8-Diisobutyl-5-methyl-1-oxa-4,7,10-triazacyclotetradecane-3,6,9,14-tetrone
PC(O-8:0/O-1:0)[U]
3,5,9-Trioxa-4-phosphaheptadecan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide
1-Piperidinecarboxylic acid, 4-[4-[[(2-hydroxy-1,1-dimethylethyl)amino]carbonyl]-2-oxo-1-pyrrolidinyl]-, 1,1-dimethylethyl ester
1-Piperidinecarboxylic acid, 4-[4-[[(2-hydroxy-1,1-dimethylethyl)amino]carbonyl]-2-oxo-1-pyrrolidinyl]-, 1,1-dimethylethyl ester
Tandospirone
Tandospirone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Tandospirone (SM-3997) is a potent and selective 5-HT1A receptor partial agonist, with a Ki of 27 nM. Tandospirone has anxiolytic and antidepressant activities. Tandospirone can be used for the research of the central nervous system disorders and the underlying mechanisms[1][2][3].
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-morpholin-4-ylacetyl)amino]oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-3-oxanyl]cyclopropanecarboxamide
(2-Hydroxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Hydroxy-3-nonoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
2-Aminoethyl (3-dodecoxy-2-hydroxypropyl) hydrogen phosphate
2-Aminoethyl (3-dodecoxy-2-hydroxypropyl) hydrogen phosphate
(3S,3aR,8aR,9aR)-3-[[2-(2-methoxyphenyl)ethylamino]methyl]-8a-methyl-5-methylidene-3a,4,4a,6,7,8,9,9a-octahydro-3H-benzo[f][1]benzofuran-2-one
(3S,3aR,8aR,9aR)-3-[[2-(2-methoxyphenyl)ethylamino]methyl]-8a-methyl-5-methylidene-3a,4,4a,6,7,8,9,9a-octahydro-3H-benzo[f][1]benzofuran-2-one
2-[(2-Acetamido-3-hydroxynonoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Acetamido-3-hydroxynonoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-[3-hydroxy-2-(propanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-[3-hydroxy-2-(propanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium
Usmarapride (free base)
Usmarapride (free base)
Usmarapride (SUVN-D4010) free base is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM). Usmarapride (SUVN-D4010) free base can be used for the research of cognitive deficits associated with Alzheimer's disease[1].
(2s)-n-[(2r,3r,4r)-3-hydroxy-5-[(5r)-5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl]-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
(2s)-n-[(2r,3r,4r)-3-hydroxy-5-[(5r)-5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl]-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
(2r,3s)-3-hydroxy-3-methyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-1-(2-phenylethyl)-5-propanoyl-2h-pyridin-4-one
(2r,3s)-3-hydroxy-3-methyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-1-(2-phenylethyl)-5-propanoyl-2h-pyridin-4-one
13-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)trideca-2,4,12-trienimidic acid
13-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)trideca-2,4,12-trienimidic acid
6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
(2s)-n-[(2s,3s,4r)-3-hydroxy-5-[(5s)-5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl]-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
(2s)-n-[(2s,3s,4r)-3-hydroxy-5-[(5s)-5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl]-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
3-hydroxy-3-methyl-2-(4-methylhex-2-en-2-yl)-1-(2-phenylethyl)-5-propanoyl-2h-pyridin-4-one
3-hydroxy-3-methyl-2-(4-methylhex-2-en-2-yl)-1-(2-phenylethyl)-5-propanoyl-2h-pyridin-4-one
(1r,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
(1r,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(5e)-10-methylundec-5-en-1-yl]penta-2,4-dienimidic acid
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(5e)-10-methylundec-5-en-1-yl]penta-2,4-dienimidic acid
(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate
(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate
7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
7-{[(1r,2s,4ar,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-5-methoxy-2-methyl-1,3-benzoxazol-6-ol
7-{[(1r,2s,4ar,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-5-methoxy-2-methyl-1,3-benzoxazol-6-ol
(1s,6s)-6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
(1s,6s)-6-(2h-1,3-benzodioxol-5-yl)-3-(4-methylpent-3-en-1-yl)-n-(2-methylpropyl)cyclohex-3-ene-1-carboximidic acid
(3e,10e)-19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
(3e,10e)-19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-butan-2-yl]trideca-2,4,12-trienimidic acid
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-butan-2-yl]trideca-2,4,12-trienimidic acid
(1r,7s,7as)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
(1r,7s,7as)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
(2e,4e,11e)-12-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)dodeca-2,4,11-trienimidic acid
(2e,4e,11e)-12-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)dodeca-2,4,11-trienimidic acid
12-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)dodeca-2,4,11-trienimidic acid
12-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)dodeca-2,4,11-trienimidic acid
n-[3-hydroxy-5-(5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl)-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
n-[3-hydroxy-5-(5-isopropyl-3,3-dimethyl-2,4-dioxopyrrolidin-1-yl)-4-methyl-5-oxopentan-2-yl]-2-(methylamino)propanimidic acid
14-hydroxy-1,5,18-trimethyl-16-(2-methylpropyl)-19-oxa-15-azapentacyclo[14.2.1.0³,¹³.0⁴,¹⁰.0¹³,¹⁷]nonadeca-2,4,14-trien-12-one
14-hydroxy-1,5,18-trimethyl-16-(2-methylpropyl)-19-oxa-15-azapentacyclo[14.2.1.0³,¹³.0⁴,¹⁰.0¹³,¹⁷]nonadeca-2,4,14-trien-12-one
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)trideca-2,4,12-trienimidic acid
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)trideca-2,4,12-trienimidic acid
[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r)-2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate
[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r)-2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]trideca-2,4,12-trienimidic acid
(2e,4e,12e)-13-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]trideca-2,4,12-trienimidic acid
13-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)trideca-2,4,12-trienimidic acid
13-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)trideca-2,4,12-trienimidic acid
(1s,10s,13s,16r,17s,18r)-14-hydroxy-1,5,18-trimethyl-16-(2-methylpropyl)-19-oxa-15-azapentacyclo[14.2.1.0³,¹³.0⁴,¹⁰.0¹³,¹⁷]nonadeca-2,4,14-trien-12-one
(1s,10s,13s,16r,17s,18r)-14-hydroxy-1,5,18-trimethyl-16-(2-methylpropyl)-19-oxa-15-azapentacyclo[14.2.1.0³,¹³.0⁴,¹⁰.0¹³,¹⁷]nonadeca-2,4,14-trien-12-one
(1s,3e,5s,7s,10e,12r,15r,16r,17r)-19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
(1s,3e,5s,7s,10e,12r,15r,16r,17r)-19-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-6-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0⁵,⁷]nonadeca-3,10,13,18-tetraen-2-one
